Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07140380 · ClinicalTrials.gov registry record · Phase 2
Phase 2b Controlled Study
A Phase 2 study of Dry Eye Disease, sponsored by IVIEW Therapeutics.
- Active
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07140380 is a Phase 2 study of Dry Eye Disease that is active but no longer recruiting, run by IVIEW Therapeutics. The registered enrollment target is 30 participants, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07140380, a Phase 2 study of Dry Eye Disease, is active but no longer recruiting, sponsored by IVIEW Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Double-masked two period controlled trial of three eyelid wipe dosing techniques
Conditions Studied
Interventions
- DRUG IVW-1001 Ophthalmic Eyelid Wipe
Study Locations (1)
California
- Eye Research Foundation - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07140380
The ClinicalTrials.gov registry entry for NCT07140380 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (88% lower). The listed sponsor is IVIEW Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 1 intervention - of which IVW-1001 Ophthalmic Eyelid Wipe is the first listed.
NCT07140380 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07140380 about?
NCT07140380 is a clinical study titled "Phase 2b Controlled Study". Double-masked two period controlled trial of three eyelid wipe dosing techniques
What is the current status of trial NCT07140380?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2025-08-20. Estimated completion is 2025-12-31.
What conditions does trial NCT07140380 study?
This clinical trial studies the following conditions: Dry Eye Disease.
What interventions are being tested in trial NCT07140380?
The interventions under investigation include: IVW-1001 Ophthalmic Eyelid Wipe (DRUG).
Who is sponsoring clinical trial NCT07140380?
This trial is sponsored by IVIEW Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07140380 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
RECRUITING · Phase 2
-
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
RECRUITING · Phase 2
-
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
ACTIVE NOT RECRUITING · Phase 2
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
COMPLETED · Phase 2
-
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
COMPLETED · Phase 2
-
A Study of TL-925 as a Treatment for Dry Eye Disease
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.